美国器官移植临床药学服务内容和模式简介

张建萍; 李聪; 魏玉辉; 孙树森; 武新安<sup>*</sup>

引用本文:	张建萍,李聪,魏玉辉,孙树森,武新安.美国器官移植临床药学服务内容和模式简介[J].中国现代应用药学,2021,38(4):481-485.
	ZHANG Jianping,LI Cong,WEI Yuhui,SUN Shusen,WU Xin'an.A Brief Introduction to the Content and Model of Clinical Pharmaceutical Service for Organ Transplantation in the United States[J].Chin J Mod Appl Pharm(中国现代应用药学),2021,38(4):481-485.

【打印本页】【HTML】【下载PDF全文】【查看/发表评论】【EndNote】【RefMan】【BibTex】

←前一篇|后一篇→

过刊浏览高级检索

本文已被：浏览 6383次下载 3252次	码上扫一扫！
分享到：微信更多字体:加大+\|默认\|缩小-
美国器官移植临床药学服务内容和模式简介
张建萍¹, 李聪², 魏玉辉¹, 孙树森³, 武新安¹
1.兰州大学第一医院药剂科, 兰州 730000;2.国药东风总医院药学部, 湖北十堰 442000;3.西新英格兰大学药学与健康科学学院, 马萨诸塞州斯普林菲尔德 01110-2612

摘要:

目的介绍美国器官移植临床药学服务内容和模式，为提升国内器官移植临床药学服务提供参考。方法通过参观学习美国器官移植中心临床药师的日常工作，总结其服务内容和模式，并分析国内药学服务的不足之处。结果美国器官移植临床药学服务覆盖供体和受体从术前到术后的全过程，并且同质化和精细化，与国内器官移植临床药学服务尚有较大差异。结论美国器官移植临床药学服务内容和模式值得学习与借鉴，国内药师应积极拓展服务内容和模式，逐渐提升药学服务。

关键词: 美国器官移植临床药学服务内容临床药学服务模式

DOI：10.13748/j.cnki.issn1007-7693.2021.04.018

分类号:R95

基金项目:

A Brief Introduction to the Content and Model of Clinical Pharmaceutical Service for Organ Transplantation in the United States

ZHANG Jianping¹, LI Cong², WEI Yuhui¹, SUN Shusen³, WU Xin'an¹

1.Department of Pharmacy, The First Hospital of Lanzhou University, Lanzhou 730000, China;2.Department of Pharmacy, Sinopharm Dongfeng General Hospital, Shiyan 442000, China;3.College of Pharmacy and Health Sciences, Western New England University, Springfield 01110-2612, United States

Abstract:

OBJECTIVE To introduce the content and model of clinical pharmaceutical service of organ transplantation in the United States and to provide reference for improving it in China. METHODS The content and model of clinical pharmaceutical service were summarized by visiting the daily work of clinical pharmacists in organ transplantation center of the United States, the shortcomings of domestic pharmaceutical service in China were analyzed. RESULTS The whole process of clinical pharmaceutical service for donors and recipients from pre-operation to post-operation was covered in the United States, it was also homogeneous and refined, which was quite different in China. CONCLUSION The content and model of clinical pharmaceutical service in organ transplantation of the United States is worth learning and applying, domestic pharmacists should actively expand the content and model of service, and gradually improved the pharmaceutical service.

Key words: United States organ transplantation content of clinical pharmaceutical service model of clinical pharmaceutical service